Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03929263 · ClinicalTrials.gov registry record · NA
Parent-Adolescent Training on Neurofeedback and Synchrony
A NA study of Testing Protocol With Healthy Individuals for Feasibility, sponsored by Oklahoma State University Center for Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT03929263 is a NA study of Testing Protocol With Healthy Individuals for Feasibility that has completed, run by Oklahoma State University Center for Health Sciences. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03929263, a NA study of Testing Protocol With Healthy Individuals for Feasibility, has completed, sponsored by Oklahoma State University Center for Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will test a real-time functional magnetic resonance imaging (fMRI) hyperscanning neurofeedback protocol for feasibility with ten mothers and their psychiatrically healthy adolescent daughters, with the eventual goal to test this in a sample of depressed adolescents in a future study.
Conditions Studied
Interventions
- BEHAVIORAL Real-time fMRI neurofeedback
Study Locations (1)
Oklahoma
- Laureate Institute for Brain Research - Tulsa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-09-25 |
| Est. Completion | 2021-02-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03929263
The ClinicalTrials.gov registry entry for NCT03929263 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oklahoma State University Center for Health Sciences, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Testing Protocol With Healthy Individuals for Feasibility appearing as the primary indexed condition, and to 1 intervention - of which Real-time fMRI neurofeedback is the first listed.
NCT03929263 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.
Frequently Asked Questions
What is clinical trial NCT03929263 about?
NCT03929263 is a clinical study titled "Parent-Adolescent Training on Neurofeedback and Synchrony". The study will test a real-time functional magnetic resonance imaging (fMRI) hyperscanning neurofeedback protocol for feasibility with ten mothers and their psychiatrically healthy adolescent daughters, with the eventual goal to test this in a sample of depressed adolescents in a future study.
What is the current status of trial NCT03929263?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2019-09-25. Estimated completion is 2021-02-27.
What conditions does trial NCT03929263 study?
This clinical trial studies the following conditions: Testing Protocol With Healthy Individuals for Feasibility.
What interventions are being tested in trial NCT03929263?
The interventions under investigation include: Real-time fMRI neurofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT03929263?
This trial is sponsored by Oklahoma State University Center for Health Sciences, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03929263 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.